Shujing Liu

7.3k total citations
53 papers, 2.3k citations indexed

About

Shujing Liu is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Shujing Liu has authored 53 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Molecular Biology, 12 papers in Cancer Research and 11 papers in Oncology. Recurrent topics in Shujing Liu's work include MicroRNA in disease regulation (6 papers), Immunotherapy and Immune Responses (6 papers) and Epigenetics and DNA Methylation (5 papers). Shujing Liu is often cited by papers focused on MicroRNA in disease regulation (6 papers), Immunotherapy and Immune Responses (6 papers) and Epigenetics and DNA Methylation (5 papers). Shujing Liu collaborates with scholars based in United States, China and Austria. Shujing Liu's co-authors include Xiaowei Xu, Wei Guo, Suresh Kumar, Michael T. Tetzlaff, Rutao Cui, Hongtao Zhang, Phyllis A. Gimotty, Ruifeng Yang, Pengpeng Zhang and Maria Cristina Guerra and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nature Communications and SHILAP Revista de lepidopterología.

In The Last Decade

Shujing Liu

51 papers receiving 2.3k citations

Peers

Shujing Liu
Xin Hu China
Wei Yu China
Zhihua Li China
Doo‐Sik Kim South Korea
Xin Hu China
Shujing Liu
Citations per year, relative to Shujing Liu Shujing Liu (= 1×) peers Xin Hu

Countries citing papers authored by Shujing Liu

Since Specialization
Citations

This map shows the geographic impact of Shujing Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shujing Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shujing Liu more than expected).

Fields of papers citing papers by Shujing Liu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shujing Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shujing Liu. The network helps show where Shujing Liu may publish in the future.

Co-authorship network of co-authors of Shujing Liu

This figure shows the co-authorship network connecting the top 25 collaborators of Shujing Liu. A scholar is included among the top collaborators of Shujing Liu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shujing Liu. Shujing Liu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhou, Liang, Shujing Liu, Wenqi Yang, et al.. (2025). The impact of exercise on the role of lipid droplets in maintaining health: a narrative review. 2(4). 231–248.
2.
Liu, Shujing, Yonghan Roh, Shrawan Kumar Mageswaran, et al.. (2025). Droplet Squeeze Microfluidic Platform for Generating Extracellular Vesicle Hybrids for Drug Delivery. Small. 21(37). e2503807–e2503807.
3.
Oh, Daniel, Min Cheng, Shujing Liu, et al.. (2025). Enhancing Chimeric Antigen Receptor T‐Cell Generation via Microfluidic Mechanoporation and Lipid Nanoparticles. Small. 21(17). e2410975–e2410975. 5 indexed citations
4.
Zhang, Haifeng, Rong Liu, Chunying Li, et al.. (2024). LRRC8A as a central mediator promotes colon cancer metastasis by regulating PIP5K1B/PIP2 pathway. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1870(4). 167066–167066. 11 indexed citations
5.
Xie, Yu, Jing Yu, Chengkun Wu, et al.. (2024). LINC00173 silence and estrone supply suppress ER+ breast cancer by estrogen receptor α degradation and LITAF activation. Cancer Science. 115(7). 2318–2332. 2 indexed citations
6.
Liu, Shujing, Wenqi Yang, Guohua Zheng, et al.. (2024). Exercise ameliorates lipid droplet metabolism disorder by the PLIN2–LIPA axis-mediated lipophagy in mouse model of non-alcoholic fatty liver disease. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1870(3). 167045–167045. 15 indexed citations
7.
Liu, Shujing, et al.. (2020). Polarization-indepentant multi-band unidirectional reflectionless propagation in non-Hermitian metamaterial. International Journal of Modern Physics B. 34(30). 2050295–2050295. 3 indexed citations
8.
Sharma, Gaurav, Rani Ojha, Estela Noguera-Ortega, et al.. (2020). PPT1 inhibition enhances the antitumor activity of anti–PD-1 antibody in melanoma. JCI Insight. 5(17). 63 indexed citations
9.
Duperret, Elizabeth K., Shujing Liu, Regina Stoltz, et al.. (2018). A Designer Cross-reactive DNA Immunotherapeutic Vaccine that Targets Multiple MAGE-A Family Members Simultaneously for Cancer Therapy. Clinical Cancer Research. 24(23). 6015–6027. 36 indexed citations
10.
Cao, Yu, et al.. (2018). Ganoderma: A Cancer Immunotherapy Review. Frontiers in Pharmacology. 9. 1217–1217. 71 indexed citations
11.
Yan, Fei, Na Shen, Jiayun Pang, et al.. (2017). A vicious loop of fatty acid-binding protein 4 and DNA methyltransferase 1 promotes acute myeloid leukemia and acts as a therapeutic target. Leukemia. 32(4). 865–873. 41 indexed citations
12.
Yan, Fei, Na Shen, Jiayun Pang, et al.. (2016). Fatty acid-binding protein FABP4 mechanistically links obesity with aggressive AML by enhancing aberrant DNA methylation in AML cells. Leukemia. 31(6). 1434–1442. 76 indexed citations
13.
Lu, Wenfu, Shujing Liu, Yingqiu Xie, et al.. (2016). SKP2 loss destabilizes EZH2 by promoting TRAF6-mediated ubiquitination to suppress prostate cancer. Oncogene. 36(10). 1364–1373. 46 indexed citations
14.
Xie, Lin, Ruifeng Yang, Shujing Liu, et al.. (2015). TR3 is preferentially expressed by bulge epithelial stem cells in human hair follicles. Laboratory Investigation. 96(1). 81–88. 7 indexed citations
15.
Gao, Xuefeng, Fei Yan, Jiang Lin, et al.. (2015). AML1/ETO cooperates with HIF1α to promote leukemogenesis through DNMT3a transactivation. Leukemia. 29(8). 1730–1740. 66 indexed citations
16.
Yan, Fei, Na Shen, Jiayun Pang, et al.. (2014). Restoration of miR-101 suppresses lung tumorigenesis through inhibition of DNMT3a-dependent DNA methylation. Cell Death and Disease. 5(9). e1413–e1413. 73 indexed citations
17.
Yang, Ruifeng, Ying Zheng, Michelle Burrows, et al.. (2014). Generation of folliculogenic human epithelial stem cells from induced pluripotent stem cells. Nature Communications. 5(1). 3071–3071. 86 indexed citations
18.
Dai, Jie, Yan Kong, Lu Si, et al.. (2013). Large-scale Analysis of PDGFRA Mutations in Melanomas and Evaluation of Their Sensitivity to Tyrosine Kinase Inhibitors Imatinib and Crenolanib. Clinical Cancer Research. 19(24). 6935–6942. 38 indexed citations
19.
Lu, Hezhe, Jianglan Liu, Shujing Liu, et al.. (2013). Exo70 Isoform Switching upon Epithelial-Mesenchymal Transition Mediates Cancer Cell Invasion. Developmental Cell. 27(5). 560–573. 52 indexed citations
20.
Smaczniak, Cezary, Richard G. H. Immink, José M. Muiño, et al.. (2012). Characterization of MADS-domain transcription factor complexes in Arabidopsis flower development. Proceedings of the National Academy of Sciences. 109(5). 1560–1565. 403 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026